Medtronic EnTrust SingleChamber Implantable Cardioverter Defibrillator with Atrial and Ventricula...

FDA Device Recall #Z-2418-2018 — Class II — June 21, 2018

Recall Summary

Recall Number Z-2418-2018
Classification Class II — Moderate risk
Date Initiated June 21, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Location Mounds View, MN
Product Type Devices
Quantity 3 units

Product Description

Medtronic EnTrust SingleChamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies and RapidRead Telemetry, D153VRC Product Usage: The implantable cardioverter defibrillator is intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias.

Reason for Recall

Medtronic has become aware of a potential for loss of high voltage and anti-tachycardia pacing therapy in EnTrust and Escudo implantable cardioverter defibrillators (ICDs) as they near elective replacement indicator (ERI) voltage. Under certain circumstances, the device may display an immediate End of Life (EOL) Observation with no prior ERI alert. Though no ERI alert is triggered, there may not be enough remaining battery capacity to charge the high voltage circuits, resulting in an excessive charge time EOL Observation, leading to a loss of high voltage and anti-tachycardia pacing therapy.

Distribution Pattern

Worldwide Distribution - US Nationwide

Lot / Code Information

Product UPN/GTIN: 00885074300245 Serial Numbers: PNT402938H PNT413911H PNT413995H

Other Recalls from Medtronic Inc., Cardiac Rhythm and He...

Recall # Classification Product Date
Z-1707-2023 Class I ICD-DR DDBB2D1 EVERA XT IS1/DF1 INTL, Model Num... May 10, 2023
Z-1737-2023 Class I CRT-D DTBA2D4 VIVA XT IS1/DF4 INTL, Model Numbe... May 10, 2023
Z-1722-2023 Class I ICD DDPA2D1G COBALT XT DR MRI DF1 GOLD, Model N... May 10, 2023
Z-1746-2023 Class I CRT-D DTBB2D4 VIVA S IS1/DF4 INTL, Model Number... May 10, 2023
Z-1739-2023 Class I CRT-D DTBA2QQ VIVA QUAD XT IS4/DF4 INTL, Model ... May 10, 2023

Frequently Asked Questions

Contact your physician immediately if you use an electrical device or implant affected by this recall. For external devices (monitors, pumps), stop using the device and contact the manufacturer for a replacement. For implanted devices (pacemakers, ICDs), your cardiologist will assess whether you need device replacement surgery — the decision depends on how dependent you are on the device and the actual failure rate observed in the field. Do not attempt to repair or modify a recalled electrical medical device yourself. Monitor for any new or unusual symptoms and report them to your doctor.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.